NCT04361279
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- The First Affiliated Hospital of College of Medicine, Zhejiang University Hangzhou, China
Clinical trial condition
Lymphoma, Non-Hodgkin
Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.
2,779 public trials
700 recruiting studies
Lymphoma, Non-Hodgkin trial results
NCT00004198
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- University of Nebraska Medical Center Omaha, Nebraska, United States
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
- Locations
-
- Northwest Georgia Oncology Centers, a Service of WellStar Cobb Hospital Marietta, Georgia, United States
- Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
- University of Missouri/Ellis Fischel Columbia, Missouri, United States
- Washington University; Wash Uni. Sch. Of Med St Louis, Missouri, United States
NCT02561273
- Conditions
- Anaplastic Large Cell Lymphoma, ALK-Positive, Anaplastic Large Cell Lymphoma, ALK-negative, Enteropathy-Associated T-Cell Lymphoma, +21 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- Stanford Cancer Institute Palo Alto, California, United States
- University of Colorado Cancer Center, Anschutz Cancer Pavilion Aurora, Colorado, United States
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
NCT01421524
- Conditions
- Adenocarcinoma, Astrocytoma, Blood Protein Disorders, +35 more
- Locations
-
- City of Hope Cancer Center Duarte, California, United States
- UCLA Neuro-Oncology Program Los Angeles, California, United States
- UCSF Helen Diller Medical Center at Parnassus Heights San Francisco, California, United States
- University Of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
NCT05137847
- Conditions
- Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Hemic and Lymphatic Diseases, +11 more
- Locations
-
- Eisai Trial Site 3 Nagoya, Japan
- Eisai Trial Site 1 Osaka, Japan
- Eisai Trial Site 2 Tokyo, Japan
NCT01524926
- Conditions
- Granuloma, Granuloma, Plasma Cell, Hemic and Lymphatic Diseases, +27 more
- Locations
-
- Hôpitaux Universitaires Bordet-Erasme - Institut Jules Bordet Brussels, Belgium
- U.Z. Gasthuisberg Leuven, Belgium
- Institut Bergonie Bordeaux, France
- Centre Georges-Francois-Leclerc Dijon, France
NCT03742921
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- Nihon Seimei Hospital Osaka, Japan
NCT01393756
- Conditions
- Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Institut Bergonié Bordeaux, France
- Polyclinique Bordeaux Nord Aquitaine Bordeaux, France
- CHU Estaing Clermont-Ferrand, France
- Hôpital Henri Mondor Créteil, France
NCT03072771
- Conditions
- Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States